
News|Articles|September 1, 2004
Atorvastatin associated with modest but clinically apparent improvement in RA symptoms
Investigators in the Trial of Atorvastatin in Rheumatoid Arthritis (TARA) assessed whether statins would reduce inflammatory symptoms in patients with RA. Patients with RA (N=116) were randomized in the double-blind, placebo-controlled trial to receive 40 mg of atorvastatin or placebo in addition to their current disease-modifying antirheumatic drug (DMARD) therapy.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Celiac Disease and Thyroid Disease in Adolescence Linked to the Development of Type 1 Diabetes in Adulthood
2
Tackling Health Inequities Through Collaboration and Community-Based Care
3
Optimal Physical Activity for Preventing Digestive System Cancers
4
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems
5
















































